AL type cardiac amyloidosis: a devastating fatal disease

Introduction Cardiac amyloidosis is a rare entity with a grave prognosis. Due to the low index of suspicion secondary to non-specific symptoms, it is often diagnosed at an advanced stage with multi-organ involvement. Methods We report a case of systemic AL amyloidosis with predominant cardiac and re...

Full description

Bibliographic Details
Main Authors: Adeel Nasrullah, Anam Javed, Thejus T Jayakrishnan, Aaron Brumbaugh, Ariel Sandhu, Brent Hardman
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2021-05-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
Online Access:http://dx.doi.org/10.1080/20009666.2021.1915547
_version_ 1797967687127662592
author Adeel Nasrullah
Anam Javed
Thejus T Jayakrishnan
Aaron Brumbaugh
Ariel Sandhu
Brent Hardman
author_facet Adeel Nasrullah
Anam Javed
Thejus T Jayakrishnan
Aaron Brumbaugh
Ariel Sandhu
Brent Hardman
author_sort Adeel Nasrullah
collection DOAJ
description Introduction Cardiac amyloidosis is a rare entity with a grave prognosis. Due to the low index of suspicion secondary to non-specific symptoms, it is often diagnosed at an advanced stage with multi-organ involvement. Methods We report a case of systemic AL amyloidosis with predominant cardiac and renal involvement associated with multiple myeloma. Case Summary A 60-year-old male presented with progressive anasarca, orthopnea and weight gain over 8 months. On clinical examination, 3+ pitting edema was found in bilateral extremities and scrotum. Serum N-type proBNP and troponin T were elevated, and EKG showed diffuse low voltage QRS, right axis deviation, and 1st degree AV block. Echocardiography revealed granular myocardium, biventricular hypertrophy, bi-atrial dilation and apical sparing pattern on global longitudinal strain which was suggestive of cardiac amyloidosis. Light chain assessment showed elevated kappa and lambda chains with kappa to lambda ratio of 16.2. Endomyocardial biopsy revealed AL type cardiac amyloidosis, and bone marrow biopsy confirmed the diagnosis of multiple myeloma. He received six cycles of bortezomib, cyclophosphamide, and dexamethasone but continued to deteriorate. He experienced an episode of cardiac arrest following which he had a return of spontaneous circulation but due to poor prognosis, the family opted for pursuing comfort measures only. Conclusions Cardiac involvement in AL type amyloidosis imparts significant morbidity and mortality. The management of cardiac amyloidosis entails a multidisciplinary approach with an emphasis on cardiology and oncology. Despite the novel diagnostic modalities and treatment regimens, the outcome for AL-type cardiac amyloidosis remains poor.
first_indexed 2024-04-11T02:33:58Z
format Article
id doaj.art-e41b19c7d8e5493fa73aff89a4a51c97
institution Directory Open Access Journal
issn 2000-9666
language English
last_indexed 2024-04-11T02:33:58Z
publishDate 2021-05-01
publisher Greater Baltimore Medical Center
record_format Article
series Journal of Community Hospital Internal Medicine Perspectives
spelling doaj.art-e41b19c7d8e5493fa73aff89a4a51c972023-01-02T20:40:03ZengGreater Baltimore Medical CenterJournal of Community Hospital Internal Medicine Perspectives2000-96662021-05-0111340741210.1080/20009666.2021.19155471915547AL type cardiac amyloidosis: a devastating fatal diseaseAdeel Nasrullah0Anam Javed1Thejus T Jayakrishnan2Aaron Brumbaugh3Ariel Sandhu4Brent Hardman5Allegheny Health NetworkAllegheny Health NetworkAllegheny Health NetworkAllegheny Health NetworkAllegheny Health NetworkAllegheny Health NetworkIntroduction Cardiac amyloidosis is a rare entity with a grave prognosis. Due to the low index of suspicion secondary to non-specific symptoms, it is often diagnosed at an advanced stage with multi-organ involvement. Methods We report a case of systemic AL amyloidosis with predominant cardiac and renal involvement associated with multiple myeloma. Case Summary A 60-year-old male presented with progressive anasarca, orthopnea and weight gain over 8 months. On clinical examination, 3+ pitting edema was found in bilateral extremities and scrotum. Serum N-type proBNP and troponin T were elevated, and EKG showed diffuse low voltage QRS, right axis deviation, and 1st degree AV block. Echocardiography revealed granular myocardium, biventricular hypertrophy, bi-atrial dilation and apical sparing pattern on global longitudinal strain which was suggestive of cardiac amyloidosis. Light chain assessment showed elevated kappa and lambda chains with kappa to lambda ratio of 16.2. Endomyocardial biopsy revealed AL type cardiac amyloidosis, and bone marrow biopsy confirmed the diagnosis of multiple myeloma. He received six cycles of bortezomib, cyclophosphamide, and dexamethasone but continued to deteriorate. He experienced an episode of cardiac arrest following which he had a return of spontaneous circulation but due to poor prognosis, the family opted for pursuing comfort measures only. Conclusions Cardiac involvement in AL type amyloidosis imparts significant morbidity and mortality. The management of cardiac amyloidosis entails a multidisciplinary approach with an emphasis on cardiology and oncology. Despite the novel diagnostic modalities and treatment regimens, the outcome for AL-type cardiac amyloidosis remains poor.http://dx.doi.org/10.1080/20009666.2021.1915547multiple myelomaal type amyloidosiscardiac failurerenal failure
spellingShingle Adeel Nasrullah
Anam Javed
Thejus T Jayakrishnan
Aaron Brumbaugh
Ariel Sandhu
Brent Hardman
AL type cardiac amyloidosis: a devastating fatal disease
Journal of Community Hospital Internal Medicine Perspectives
multiple myeloma
al type amyloidosis
cardiac failure
renal failure
title AL type cardiac amyloidosis: a devastating fatal disease
title_full AL type cardiac amyloidosis: a devastating fatal disease
title_fullStr AL type cardiac amyloidosis: a devastating fatal disease
title_full_unstemmed AL type cardiac amyloidosis: a devastating fatal disease
title_short AL type cardiac amyloidosis: a devastating fatal disease
title_sort al type cardiac amyloidosis a devastating fatal disease
topic multiple myeloma
al type amyloidosis
cardiac failure
renal failure
url http://dx.doi.org/10.1080/20009666.2021.1915547
work_keys_str_mv AT adeelnasrullah altypecardiacamyloidosisadevastatingfataldisease
AT anamjaved altypecardiacamyloidosisadevastatingfataldisease
AT thejustjayakrishnan altypecardiacamyloidosisadevastatingfataldisease
AT aaronbrumbaugh altypecardiacamyloidosisadevastatingfataldisease
AT arielsandhu altypecardiacamyloidosisadevastatingfataldisease
AT brenthardman altypecardiacamyloidosisadevastatingfataldisease